Prostate Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Prostate Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Mar 01, 2018

---

• NCCN Updates Prostate Cancer Management Guidelines,  
  Journal of Clinical Pathways, February 23, 2018
• The Use of Biomarkers in Prostate Cancer Screening and Treatment.  
  Ashley V Alford et al. Reviews in urology 2017 19(4) 221-234
• Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study.  
  Eng Kevin H et al. PLoS genetics 2018 Feb 14(2) e1007194
• Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.  
  Kirkegaard Pia et al. BMC family practice 2018 Feb 19(1) 32
• A Personal Attack: New genetic findings in prostate cancer are opening up more precise therapies for men with advanced metastatic disease.  
  J Erdmann, Genome Magazine, Jan 2018
• Electronic health record problem lists: accurate enough for risk adjustment?  
  Daskivich Timothy J et al. The American journal of managed care 2018 Jan 24(1) e24-e29
• Male BRCA mutation carriers: clinical characteristics and cancer spectrum.  
  Ibrahim Mohammed et al. BMC cancer 2018 Feb 18(1) 179
• The Clinical Impact of BRCA2 Loss in Prostate Cancer.  
  Bryant Helen E et al. European urology 2016 69(6) 996-7
• Liquid Biopsy in Prostate Cancer: A Case for Comprehensive Genomic Characterization of Circulating Tumor Cells.  
  Boral Debasish et al. Clinical chemistry 2018 Feb 64(2) 251-253
• How can polygenic inheritance be used in population screening for common diseases?  
  Khoury Muin J et al. Genetics in medicine : official journal of the American College of Medical Genetics 2013 Jun 15(6) 437-43